L.E.K.’s Take on China Medtech: Optimistic Macro View, Short-Term Hit Hard Stephen Sunderland Read more
Related Practice MedTech Despite the COVID-19 lockdown, Stephen Sunderland foresees limited disruption 07102020100744
Article Life Sciences & Pharma Clinical Trial Design Strategies To Address Methodological Challenges in Psychedelics November 15, 2024
Published Articles Business Services What do leaders get wrong when making high-risk decisions? October 10, 2024
Executive Insights Biotech and Pharmaceuticals Drug Manufacturing Trends Impacting Biopharma Stakeholders in the Post-COVID-19 Era May 23, 2024
Case Study Biotech and Pharmaceuticals Pricing Strategy for a Recently Commercialized Rheumatoid Arthritis Drug April 30, 2024 A biopharma company with a recently launched rheumatoid arthritis drug asked L.E.K. Consulting to define the optimal price strategies for the 12-18 months…
Executive Insights Diagnostics, Tools and Personalized Medicine Commercial Excellence in Life Sciences Tools and Services Companies April 8, 2024
